Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by DamnYankeeson Feb 10, 2016 9:29am
194 Views
Post# 24543139

RE:RE:RE:February 2 press release states FS on February 12 and

RE:RE:RE:February 2 press release states FS on February 12 andA second P3, that follows up on a small P3 that nearly saw approval, should be worth a substantial sum once the trial framework is in place. Reading through some notes, I believe that the CEO said, not long after he was hired, that the real value in the company lies in the P3b framework and whether it could attain fast track status. Whether it be for a sale or a partnership. Will the company choose to sell it for a sizeable amout? Maybe and maybe not.
<< Previous
Bullboard Posts
Next >>